Spots Global Cancer Trial Database for Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Official Title: Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository

Study ID: NCT00898482

Conditions

Pancreatic Cancer

Interventions

This is a non-intervention study for all groups.

study of socioeconomic and demographic variables

Study Description

Brief Summary: RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy participants to test in the laboratory may help the study of cancer in the future. PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic cancer and healthy participants.

Detailed Description: OBJECTIVES: * Establish a central pancreatic cancer specimen (including serum and peripheral blood lymphocytes) repository to serve as a resource for current or future scientific studies. * Utilize the clinical database to perform clinicopathologic correlation with the results of those studies. * Test new hypotheses as they emerge. OUTLINE: This is a prospective study. Blood is collected from patients with pancreatic cancer at baseline and then every 3-6 months for up to 2 years. All other participants have blood collected at baseline and complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and peripheral blood lymphocytes obtained from the blood samples are frozen and stored. PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for this study.